Hygeia Healthcare Holdings マネジメント

マネジメント基準チェック /44

Hygeia Healthcare Holdingsの CEO はYiwen Zhuで、 Aug2021年に任命され、の在任期間は 3.25年です。の年間総報酬はCN¥ 2.49Mで、 24.1%給与と75.9%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の44.98%を直接所有しており、その価値はHK$ 4.60B 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と5年です。

主要情報

Yiwen Zhu

最高経営責任者

CN¥2.5m

報酬総額

CEO給与比率	24.1%
CEO在任期間	3.3yrs
CEOの所有権	45.0%
経営陣の平均在職期間	3.8yrs
取締役会の平均在任期間	5yrs

経営陣の近況

Recent updates

CEO報酬分析

Hygeia Healthcare Holdings の収益と比較して、Yiwen Zhu の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Jun 30 2024	n/a	n/a	CN¥733m
Mar 31 2024	n/a	n/a	CN¥708m
Dec 31 2023	CN¥2m	CN¥600k	CN¥683m
Sep 30 2023	n/a	n/a	CN¥635m
Jun 30 2023	n/a	n/a	CN¥587m
Mar 31 2023	n/a	n/a	CN¥532m
Dec 31 2022	CN¥4m	CN¥492k	CN¥477m
Sep 30 2022	n/a	n/a	CN¥472m
Jun 30 2022	n/a	n/a	CN¥468m
Mar 31 2022	n/a	n/a	CN¥455m
Dec 31 2021	CN¥709k	CN¥239k	CN¥441m
Sep 30 2021	n/a	n/a	CN¥403m
Jun 30 2021	n/a	n/a	CN¥365m
Mar 31 2021	n/a	n/a	CN¥268m
Dec 31 2020	CN¥45k	CN¥37k	CN¥170m
Sep 30 2020	n/a	n/a	CN¥100m
Jun 30 2020	n/a	n/a	CN¥29m
Mar 31 2020	n/a	n/a	CN¥35m
Dec 31 2019	CN¥779k	CN¥684k	CN¥40m

報酬と市場: Yiwenの総報酬 ($USD 344.08K ) は、 Hong Kong市場 ($USD 487.65K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Yiwenの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Yiwen Zhu (60 yo)

3.3yrs

在職期間

CN¥2,493,000

報酬

Mr. Yiwen Zhu serves as Executive Director & Co-Chief Executive Officer of at Hygeia Healthcare Holdings Co., Limited since August 23, 2021. He serves as Chairman of the Board at Hygeia Healthcare Holdings...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Yiwen Zhu	Chairman & Co-CEO	3.3yrs	CN¥2.49m	44.98% HK$ 4.6b
Huanhuan Cheng	Co-CEO & Executive Director	3.3yrs	CN¥1.54m	データなし
Wenshan Zhang	Director of Research & Development	4.8yrs	CN¥1.51m	0.0052% HK$ 528.4k
Hui Jiang	Director of Radiotherapy Division & Executive Director	3.9yrs	CN¥1.33m	データなし
Ai Ren	Joint Company Secretary	no data	CN¥2.32m	0.46% HK$ 46.8m
Xue Yu	Financial Director	no data	データなし	データなし
Kwok Yin Lau	Joint Company Secretary	3.8yrs	データなし	データなし

3.8yrs

平均在職期間

42yo

平均年齢

経験豊富な経営陣: 6078の経営陣は経験豊富であると考えられます ( 3.8年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Yiwen Zhu	Chairman & Co-CEO	3.7yrs	CN¥2.49m	44.98% HK$ 4.6b
Huanhuan Cheng	Co-CEO & Executive Director	5.4yrs	CN¥1.54m	データなし
Wenshan Zhang	Director of Research & Development	4.8yrs	CN¥1.51m	0.0052% HK$ 528.4k
Hui Jiang	Director of Radiotherapy Division & Executive Director	3.9yrs	CN¥1.33m	データなし
Ai Ren	Joint Company Secretary	6.2yrs	CN¥2.32m	0.46% HK$ 46.8m
Changqing Ye	Independent Non-Executive Director	5.2yrs	CN¥240.00k	データなし
Chun Zhao	Independent Non-Executive Director	2.5yrs	CN¥240.00k	データなし
Yanqun Liu	Independent Non-Executive Director	5.2yrs	CN¥240.00k	データなし

5.0yrs

平均在職期間

51yo

平均年齢

経験豊富なボード: 6078の取締役会は経験豊富であると考えられます ( 5年の平均在任期間)。

Hygeia Healthcare Holdings マネジメント

マネジメント 基準チェック /44

主要情報

経営陣の近況

Chairman & Co-CEO recently bought HK$13m worth of stock

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Chairman & Co-CEO recently bought HK$9.0m worth of stock

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Recent updates

Investor sentiment improves as stock rises 34%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

First half 2024 earnings released: EPS: CN¥0.61 (vs CN¥0.53 in 1H 2023)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Chairman & Co-CEO recently bought HK$13m worth of stock

Investor sentiment improves as stock rises 21%

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Investor sentiment deteriorates as stock falls 24%

Chairman & Co-CEO recently bought HK$9.0m worth of stock

First half 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 1H 2022)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2023 Results on Aug 29, 2023

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into the acquisition agreement to acquire Datang International (Hong Kong) Limited for CNY 1.2 billion.

Now 22% undervalued after recent price drop

Upcoming dividend of CN¥0.15 per share at 0.4% yield

Full year 2022 earnings released: EPS: CN¥0.77 (vs CN¥0.71 in FY 2021)

Hygeia Healthcare Holdings Co., Limited has completed a Follow-on Equity Offering in the amount of HKD 791.8 million.

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) acquired 30% of KAIYUAN JIEHUA HOSPITAL CO., LTD for CNY 15.3 million.

First half 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.32 in 1H 2021)

Hygeia Healthcare Holdings Co., Limited Omits Dividend for the Six Months Ended June 30, 2022

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Hygeia Healthcare Holdings Co., Limited Resolves Not to Declare Final Dividend for the Year Ended December 31, 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Chairman & Co-CEO recently bought HK$15m worth of stock

Joint Company Secretary recently bought HK$11m worth of stock

Investor sentiment deteriorated over the past week

Chairman & Co-CEO recently bought HK$4.4m worth of stock

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

Board Member recently sold HK$6.2m worth of stock

Director of Research & Development recently sold HK$2.7m worth of stock

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into a share purchase agreement to acquire 98% stake in Suzhou Yongding Hospital from Ascendent Capital Partners I, L.P. managed by Ascendent Capital Partners (Asia) Limited for CNY 1.7 billion.

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /44